Västra Hamnen Corp. Finance

Bioextrax: Sweet dreams of a bright 2024

  • Joint Development Agreement with the candy producer in Q1
  • Progression in several projects, funding risk remains
  • Our model implies a fair valuation of SEK 7.60 per share

A quiet final quarter of 2023 was followed by an eventful start of 2024 for Lund-based Bioextrax. In January, the American startup terminated the contract due to financial issues. For Bioextrax, the financial impact of the cancellation was limited according in our valuation model. However, the stock market reaction on the news was harsh sending the share price down by 30 per cent.

The initial research report is available here.

Datum 2024-02-16, kl 19:00
Källa MFN
Investera som eToros bästa investerare! Med eToros CopyTrader™, kan du automatiskt kopiera andra investerares beslut. Hitta investerare som du tror på och kopiera deras investeringar i realtid. Inga extra avgifter tas ut för funktionen.
Copy Trading innebär inte investeringsrådgivning. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.